The ANTARCTIC Study - Assessment of a Normal Versus Tailored Dose of Prasugrel After Stenting in Patients Aged > 75 Years to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications
Latest Information Update: 20 Feb 2024
Price :
$35 *
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Thrombosis
- Focus Therapeutic Use
- Acronyms ANTARCTIC
- 30 Jun 2021 Results of a sub-study (ANTARCTIC-Bleeding study) assessing the incidence and the predictive factors of bleeding and to assess the impact of bleeding on further ischemic outcomes in elderly patients published in the American Journal of Cardiovascular Drugs
- 29 Aug 2018 Results of a pooled analysis from ARCTIC and ANTARCTIC trials, presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology
- 29 Aug 2018 Results of the sub-study assessing the predictive value of platelet function testing on occurrence of bleedings, presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology